Daratumumab, Bortezomib And Dexamethasone (Dvd) Vs Bortezomib And Dexamethasone (Vd) In Relapsed Or Refractory Multiple Myeloma (Rrmm): Efficacy And Safety Update (Castor).

S. Lentzsch,K. Weisel,Maria-Victoria Mateos,V. Hungria,M. Munder,A. Nooka,T. Mark,H. Quach, E. Scott, J. Lee,P. Sonneveld,Tineke Casneuf,Christopher Chiu,Xiang Qin,H. Amin,P. Thiyagarajah,J. Schecter,M. Qi,A. Spencer

JOURNAL OF CLINICAL ONCOLOGY（2017）

Cited 8|Views28

No score

Abstract

8036Background: Daratumumab (D), a human, CD38-targeting mAb, is well tolerated and induces deep and durable responses in patients (pts) with RRMM. We provide an update of CASTOR (NCT02136134), a m...

Translated text

Key words

Rituximab

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined